Latest News about MRNA
Recent news which mentions MRNA
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
From InvestorPlace
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
From Benzinga
U.S. excess death toll has climbed above one million during the pandemic; ‘We’ve never seen anything like it,’ says CDC official
February 16, 2022
From MarketWatch
Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs
February 16, 2022
Tickers
MRNA
From Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
From Benzinga
Novavax Investors Can Finally Breathe a Sigh of Relief
February 16, 2022
From Motley Fool
Will Novavax Stock Ever Hit $300 Again?
February 16, 2022
From Motley Fool
The end of the pandemic may be in sight, says Moderna CEO
February 16, 2022
From MarketWatch
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
From InvestorPlace
Twilio’s Post-Pandemic Story Looks Good
February 15, 2022
From InvestorPlace
52 Biggest Movers From Yesterday
February 15, 2022
From Benzinga
PLTR Stock: Why Palantir Is Trending on Reddit’s WallStreetBets Today
February 14, 2022
From InvestorPlace
INTC Stock: 9 Things to Know About Mobileye’s Fully Autonomous Shuttles Coming in 2024
February 14, 2022
From InvestorPlace
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
From Benzinga
Is MRNA Stock a Buy Following 12% Plunge? 5 Analysts Weigh In.
February 14, 2022
Tickers
MRNA
From InvestorPlace
Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know
February 14, 2022
Tickers
MRNA
From Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 14, 2022
From Benzinga
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Sliding Today
February 14, 2022
From Motley Fool
From MarketWatch
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
February 12, 2022
From Motley Fool
5 Struggling Stocks to Buy at a Discount
February 12, 2022
From Motley Fool
2 Beaten-Down Growth Stocks to Buy and Hold for a Decade
February 11, 2022
From Motley Fool
From Benzinga
1 Green Flag For Novavax in 2022, and 1 Red Flag
February 11, 2022
From Motley Fool
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
February 11, 2022
Tickers
MRNA
From Motley Fool
Elon Musk Elected Into The National Academy Of Engineering
February 10, 2022
From Benzinga
Novavax Stock Is a Buy After This Overdone Sell-Off
February 09, 2022
From InvestorPlace
Down 52% In 3 Months, Is Moderna Stock a Bargain Buy?
February 09, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.